June 1, 2020 / 9:01 PM / a month ago

BRIEF-Ligand CEO Issues Letter To Captisol Customers

June 1 (Reuters) - Ligand Pharmaceuticals Inc:

* LIGAND CEO ISSUES LETTER TO CAPTISOL CUSTOMERS

* LIGAND PHARMACEUTICALS - IN JANUARY, GILEAD INFORMED CO THEY NEEDED CAPTISOL FOR REMDESIVIR AS POTENTIAL TREATMENT FOR COVID-19

* LIGAND PHARMACEUTICALS INC - EXPECT GILEAD’S CAPTISOL REQUIREMENTS WILL INCREASE SIGNIFICANTLY OVER NEXT COUPLE OF YEARS

* LIGAND PHARMACEUTICALS INC - PREPARED TO FILL FULL PRODUCTION AND SUPPLY NEEDS FOR ALL COMPANIES PRODUCING REMDESIVIR

* LIGAND - PLAN TO DEPLOY UP TO $60 MILLION OVER NEXT YEAR TO INCREASE CAPTISOL PRODUCTION CAPACITY TO AS MUCH AS 500 MT PER YEAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below